Table 1.
Demographics and disease characteristics of subjects
| Chronic hepatitis B (n = 218) | Healthy controls (n = 60) | |
|---|---|---|
| Median (IQR)† | ||
| Gender (M/F) | 172/46 | 29/31 |
| Age (Years old) | 32 (26‐40) | 30.5 (27.0‐38.0) |
| AST (U/L) | 50.0 (29.0‐112.0)* | 18.0 (16.0‐21.0) |
| ALT (U/L) | 66.0 (33.0‐167.8)* | 15 (12‐18) |
| ALB (g/L) | 44.55 (41.08‐46.40)* | 46.85 (45.17‐48.83) |
| GLB (g/L) | 28.25 (25.93‐30.80) | 28.10 (26.00‐29.90) |
| TBiL (umol/L) | 14.60 (11.10‐21.30)* | 11.60 (8.60‐13.10) |
| γGT (U/L) | 50.00 (24.00‐92.00)* | 18.00 (14.50‐22.00) |
| BUN (mmol/L) | 4.280 (3.450‐5.115) | 4.040 (3.422‐4.785) |
| HBV DNA | 6.22 (3.70‐8.12)a | ‐ |
| HBsAg | 3.55 (2.95‐4.41)a | ‐ |
| HBeAg | ||
| Positive | 120 | ‐ |
| Negative | 95 | |
| Missing | 3 | |
ALB, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase;TBil, total bilirubin; γ‐GT, gamma glutamyl transferase; BUN, blood urea nitrogen; IQR, interquartile range.
a
Data expressed in log(IU/mL)
*
P < 0.05 when compared with healthy controls.